Description
Bosuvi 400mg Tablet is a medication containing the active ingredient Bosutinib. Bosutinib is a tyrosine kinase inhibitor (TKI) that works by blocking the activity of certain enzymes, specifically BCR-ABL and Src family kinases, which are involved in the growth and proliferation of cancer cells. By inhibiting these enzymes, Bosuvi helps to slow down or stop the growth of cancer cells, particularly in certain types of leukemia. It is indicated for the treatment of adults with newly diagnosed chronic phase, accelerated phase, or blast phase Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML).
The recommended starting dose for Bosuvi 400mg Tablet is typically 400mg taken orally once daily. Dosage adjustments may be made by a healthcare professional based on individual response and tolerance. It is important to take this medication exactly as prescribed by your doctor, usually with food, and to avoid grapefruit or grapefruit juice while taking it, as this can increase the levels of the drug in your body. Common side effects may include diarrhea, nausea, vomiting, abdominal pain, rash, fatigue, and fever. Serious side effects can occur, so it is crucial to report any unusual symptoms to your doctor immediately. Store Bosuvi 400mg Tablet at room temperature, away from moisture and heat, and keep out of reach of children.
